IPO Guru
Closed SME

Credent Connect N Care SME IPO

Credent Connect N Care IPO — date, price band, GMP & allotment 2026

Credent Connect N Care Limited provides healthcare support services and cold chain logistics on a B2B basis. It serves diagnostic labs, hospitals and pharma companies with sample collection, laboratory manpower, temperature controlled transport and corporate wellness programmes.

Stock price

Credent Connect N Care is listed — here is the live share price.

Loading market data…
The verdict
Awaited
No analyst reviews yet
Read the reviews →
Grey market premium
₹92
+48.68% over ₹189 issue price
GMP history →
Subscribed
142.38×
Overall, across all categories
Fully subscribed Live subscription →
Minimum to apply
₹2,26,800
2 lots · 1200 shares at ₹189
Size my application →
Abhishek Vohera, Founder of IPO Guru Researched & reviewed by Abhishek Vohera, Founder, IPO Guru Last updated Figures sourced from the RHP, BSE & NSE

Timetable

Key dates from opening to listing. Today is 16 September.

Key dates Listed
  1. Open 13 Aug 2026
  2. Close 17 Aug 2026
  3. Allotment 18 Aug 2026
  4. Refund/credit 19 Aug 2026
  5. Listing 20 Aug 2026

Issue summary

The terms of the offer, as filed.

IPO Dates 13 to 17 Aug, 2026
Price Band ₹179 – ₹189
Face Value ₹10
Lot Size 600 Shares
Issue Size ₹93.9 Cr
Sale Type Fresh capital only
Listing On NSE SME
Registrar KFin Technologies Limited
Min Investment ₹ 2,26,800
Reservation
QIB
NII 21.38%
Retail 50%

Share of the offer set aside for each investor category, as stated in the offer document.

What will it cost me?

Bidding is in multiples of 600 shares at the ₹189 cut-off. The SME retail application is a fixed 2 lots; HNI starts at 3.

shares
lots lots
If it lists at today's grey market premium of ₹92
on
Grey market premium is an unofficial, unregulated indicator. It is not a forecast.
Application Lots Shares Amount
Retail (min) 2 1,200 ₹2,26,800
Retail (max) 2 1,200 ₹2,26,800
HNI (min) 3 1,800 ₹3,40,200

Strengths & risks

Drawn from the offer document — the case for and against, side by side.

Strengths · 8

  • 01The company offers logistics, manpower, diagnostics support and wellness services together, so a hospital or lab can get several needs met from one vendor.
  • 02It works pan India through warehouses, branch offices, its own vehicles and field staff, which is difficult for a new competitor to build quickly.
  • 03Cold chain and time bound transport of test samples is a specialised job and needs proper systems, which acts as an entry barrier.
  • 04The B2B model with laboratories and hospitals gives repeat and contract based business rather than one time sales.
  • 05It has built technology platforms of its own such as C3 Post for courier aggregation and C3 HRMS for managing its large workforce.
  • 06The company holds ISO 9001:2015 and ISO 15189:2022 certification, the second one being specific to medical laboratories.
  • 07Net worth improved from Rs 13.66 crore to Rs 15.90 crore and EBITDA from Rs 4.30 crore to Rs 4.99 crore between FY2024 and FY2025.
  • 08Rs 29.80 crore of the issue money goes into its wholly owned subsidiary Credent Healthcare for working capital and machinery.

Risks · 8

  • 01Profit fell in the latest year shown in the offer document. Profit after tax came down from Rs 2.66 crore in FY2024 to Rs 2.25 crore in FY2025, even though income rose slightly from Rs 76.02 crore to Rs 78.23 crore.
  • 02The margin is very thin. Profit after tax of Rs 2.25 crore on total income of Rs 78.23 crore works out to under 3%.
  • 03The issue size of Rs 93.90 crore is large compared to the size of the business. Net worth was only Rs 15.90 crore and profit only Rs 2.25 crore as on 31 March 2025.
  • 04This is a people heavy business. It runs with 6,338 workers for about Rs 78 crore of income, so any rise in wages directly eats into the small margin.
  • 05More than a third of the workforce, 2,286 out of 6,338, is on contract, which brings attrition and compliance risk.
  • 06The company has grown through acquisitions of three companies. Merging different businesses does not always work out as planned.
  • 07Rs 37.00 crore of the money is for its own working capital, which shows that a lot of money stays blocked in receivables from hospitals and labs.
  • 08This is an SME issue. One lot is 600 shares, which is about Rs 1.13 lakh at the upper band of Rs 189, and SME shares usually trade in low volume after listing.

The numbers

All figures in ₹ crore, as reported in the Credent Connect N Care offer document.

Total income
78.23
76
78
31 Mar 202431 Mar 2025
Profit after tax
2.25
3
2
31 Mar 202431 Mar 2025
EBITDA
4.99
4
5
31 Mar 202431 Mar 2025
Borrowing vs net worth
7.42 / 15.90
31 Mar 202431 Mar 2025
Borrowing Net worth
Metric 31 Mar 2025 31 Mar 2024
Assets 29.50 26.41
Total Income 78.23 76.02
Profit After Tax 2.25 2.66
EBITDA 4.99 4.30
NET Worth 15.90 13.66
Reserves and Surplus 15.70 13.46
Total Borrowing 7.42 6.85

See how this IPO compares — view listing performance of all SME IPOs.

Valuation & key ratios

Ratios are for the latest full financial year reported in the Credent Connect N Care RHP. EPS and P/E are post-issue — the table below carries the pre-issue comparison.

P/E Ratio
18.68
EPS (₹)
10.12
RoCE
16.96%
RoNW
14.13%
PAT Margin
2.88%

Credent Connect N Care IPO Valuation

How the issue prices the company before and after the fresh shares are created.

Valuation Metric Post-Issue
EPS (₹) ₹10.12
P/E Ratio (x) 18.68
Market Cap at Offer Price (₹ Cr) ₹42.02

Pre-issue figures use the shareholding reported in the RHP; post-issue figures use the shareholding once the fresh issue has created new shares. The two differ because of that dilution and because post-issue earnings per share are often annualised, so the change can run in either direction. Market capitalisation is calculated at the ₹189 offer price. Compare the post-issue P/E against listed peers before deciding — a premium there is growth you are paying for in advance.

Where the money goes

₹72.80 Cr of the issue is earmarked to named objects.

Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement ₹26.80 Cr
Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery ₹3.00 Cr
To meet Working Capital Requirements ₹37.00 Cr
Repayment and/or repayment, in full or part, of borrowing availed by the Company ₹6.00 Cr
General corporate purposes Not stated

About the company

Credent Connect N Care Limited was started in June 2015 as Credent Cold Chain Logistics Private Limited. The company provides healthcare support services and healthcare logistics. It works mainly on a B2B basis, that is it serves other businesses such as diagnostic laboratories, IVD companies, pharma companies, hospitals and clinics, and not patients directly.

Its services include home sample collection through trained phlebotomists, supplying laboratory and phlebotomy manpower to hospitals, diagnostic and paramedical services, healthcare logistics, and corporate wellness programmes. Its logistics work covers movement of test samples, medical supplies and reagents in temperature controlled and time bound conditions, including cold chain transport. It also runs a courier aggregation platform called C3 Post and a corporate wellness business under the C3 Wellness brand which does health camps, vaccination drives and preventive health check ups.

The company works across India through warehouses, branch offices, its own vehicles and field staff. It has grown partly through acquisitions, including Credent Healthcare Private Limited, Credent Team Private Limited and Alltrak Technologies Private Limited. It holds ISO 9001:2015 and ISO 15189:2022 certification. As on 31 March 2026 it had 6,338 people working with it, of which 4,052 were on its payroll and 2,286 were on contract.

Interested in this IPO? Check the live subscription status or browse all upcoming SME IPOs.

Promoters
Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma and Tanveen
Promoter holding
87.64% 63.75%
Pre-issue → post-issue
Registered office
B-3, Second Floor, Nimri Commercial Complex, Ashok Vihar, Phase-4, Delhi, New Delhi, 110052
+91-9971777199

The bankers & the filings

Who is running the book, and the documents this page is built from.

Book-running lead manager
Hem Securities Ltd. View track record →

Lead Manager Track Record

How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.

Hem Securities Ltd.

13 issues handled
Listed in Profit 75% 6 of 8 listed
Avg Listing Gain +19.9% across 8 issues
Listed Below Issue 2 of 8 listed

Best listing: Qualiance International (+77.1%). Weakest: E to E Transportation Infrastructure (0.0%).

Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.

Company contact

Company
Credent Connect N Care
Email

Frequently asked

What is the GMP of Credent Connect N Care?

The current Grey Market Premium is ₹92, or 48.68% over the issue price.

What is the Credent Connect N Care IPO price band?

₹179 to ₹189, on a face value of ₹10.

When is the allotment?

The basis of allotment is 18 August 2026, with listing on 20 August 2026.

How do I check allotment status?

On the IPO Guru allotment page or on the registrar's site — KFin Technologies Limited.

Credent Connect N Care IPO

Every number here traces back to a filing.

IPO Guru tracks GMP, subscription and allotment for every SME and Mainboard issue. Every number on this page is sourced from the RHP, BSE & NSE.

Join the WhatsApp channel All SME IPOs

Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.

GMP
₹92
Subscribed
142.38×
Min bid
₹2,26,800
Size my application